ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, ¼¼°è ¹× Áö¿ªº° Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® º¸°í¼­ : ±â¼úº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Noninvasive Fat Reduction Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology, End User, and Geography
»óǰÄÚµå : 1482348
¸®¼­Ä¡»ç : The Insight Partners
¹ßÇàÀÏ : 2024³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 145 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,450 £Ü 6,283,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.
US $ 6,450 £Ü 9,107,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,450 £Ü 11,931,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀå ±Ô¸ð´Â 2023³â 18¾ï ´Þ·¯¿¡¼­ 2031³â 61¾ï ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2031³â »çÀÌ 16.5%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ºñ¼ö¼úÀû Áö¹æ °¨¼Ò ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ºñħ½ÀÀû Áö¹æ °¨¼Ò ½Ã¼ú¿¡ µû¸¥ ÇÕº´ÁõÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

º¸°í¼­ ±¸ºÐ ¹× Á¶»ç ¹üÀ§:

ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀå ºÐ¼®Àº ´ÙÀ½°ú °°Àº ºÎ¹®À» °í·ÁÇÏ¿© ¼öÇàµË´Ï´Ù. ±â¼ú ¹× ÃÖÁ¾»ç¿ëÀÚ

¼ºÀå ÃËÁø¿äÀÎ:

ºñ¼ö¼úÀû Áö¹æ °¨¼Ò ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

ºñ¼ö¼úÀû Áö¹æ °¨¼Ò ¹æ¹ýÀº ¼¼Æ÷ »ç¸êÀ» À¯µµÇÏ¿© Ç¥Àû ºÎÀ§¿¡¼­ Áö¹æ ¼¼Æ÷¸¦ Á¦°ÅÇÏ¿© ÇÇÇÏ Áö¹æ ÁÖ¸Ó´Ï(ÇǺΠ¾Æ·¡ ¶Ç´Â ±ÙÀ° À§¿¡ Ä§ÂøµÈ Áö¹æ)¸¦ °¨¼Ò½Ãų ¼ö ÀÖ½À´Ï´Ù. ºñ¼ö¼úÀû Áö¹æ °¨¼Ò ¹æ¹ýÀº ³Ãµ¿ Áö¹æ ºÐÇØ¹ý, ÁÖ»ç Áö¹æ ºÐÇØ¹ý, °íÁÖÆÄ Áö¹æ ºÐÇØ¹ý, ·¹ÀÌÀú Áö¹æ ºÐÇØ¹ý µî ÷´Ü ±â¼úÀ» »ç¿ëÇÕ´Ï´Ù.

±â¼úº°·Î ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀåÀº ³Ãµ¿ Áö¹æ ºÐÇØ, ·¹ÀÌÀú Áö¹æ ºÐÇØ, ÃÊÀ½ÆÄ ¹× ±âŸ·Î ºÐ·ùµË´Ï´Ù. ³Ãµ¿Áö¹æºÐÇØ¼ú ºÎ¹®Àº 2023³â °¡Àå Å« ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϸç 2023-2031³â »çÀÌ 17.8%ÀÇ °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀϹÝÀûÀ¸·Î "Äð½ºÄÃÇÁÆÃ"À¸·Î ¾Ë·ÁÁø ³Ãµ¿ Áö¹æ ºÐÇØ´Â Ç¥Àû ºÎÀ§¸¦ Àú¿Â¿¡ ³ëÃâ½ÃÄÑ Áö¹æ ¼¼Æ÷¸¦ ÆÄ±«Çϱâ À§ÇØ ¼öÇàµÇ´Â ÀýÂ÷ÀÔ´Ï´Ù. ÀÌ´Â ±¹¼Ò Áö¹æ °¨¼Ò¸¦ À§ÇØ Àü ¼¼°èÀûÀ¸·Î ½ÃÇàµÇ´Â °¡Àå ¾ÈÀüÇϰí È¿°úÀûÀÎ ¹Ì¿ë ½Ã¼ú Áß ÇϳªÀÔ´Ï´Ù. ¹Ì±¹ ¼ºÇü¿Ü°úÇÐȸ(American Society of Plastic Surgeons)ÀÇ 2024³â º¸°í¼­¿¡ µû¸£¸é, Àü ¼¼°èÀûÀ¸·Î 45¸¸ °ÇÀÇ ³Ãµ¿Áö¹æºÐÇØ¼ú ½Ã¼úÀÌ ½ÃÇàµÈ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

Áö¿ªº° ºÐ¼®:

ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀå º¸°í¼­ÀÇ Á¶»ç ¹üÀ§´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áß³²¹Ì, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«À̸ç, 2022³â ºÏ¹Ì°¡ ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¹Ì±¹Àº ºÏ¹Ì ½ÃÀå¿¡¼­ °¡Àå Å« ±â¿©¸¦ ÇÏ´Â ±¹°¡ÀÔ´Ï´Ù. ¹Ì±¹ÀÎµé »çÀÌ¿¡¼­ ¿Ü¸ð¿Í Àü¹ÝÀûÀÎ °Ç°­À» °³¼±ÇÏ·Á´Â ÀνÄÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀ¸·Î °üÂûµË´Ï´Ù. ¹Ì±¹ÀεéÀº Àü¹ÝÀûÀΠü°ÝÀ» °³¼±Çϱâ À§ÇØ ºñ¸¸ ¼ö¼ú ÈÄ ½Åü À±°ûÀ» Çü¼ºÇÏ´Â ½Ã¼úÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ¼ºÇü¿Ü°úÇÐȸ(American Society of Plastic Surgeons)ÀÇ 2024³â º¸°í¼­¿¡ µû¸£¸é, ¹Ì±¹ÀÎÀÇ ¾à 70%°¡ ºñ¼ö¼úÀû Áö¹æ °¨¼Ò ¹æ¹ýÀ¸·Î ºñ¸¸À» ºü¸£°Ô ÇØ°áÇϱâ À§ÇØ ÀüȯÇϰí ÀÖ½À´Ï´Ù.

Ç¥: ¹Ì±¹¿¡¼­ ½ÃÇàµÈ ºñ¼ö¼úÀû Áö¹æ °¨¼Ò ¹æ¹ý ¹× ºñ¼ö¼úÀû ½Ã¼ú Ƚ¼ö

¸ð¼ö ÃßÁ¤Ä¡ ºñ¼ö¼úÀû Áö¹æ °¨¼Ò ½Ã¼úÀÇ ºñÀ² Àüü ºñ¼ö¼úÀû ½Ã¼ú¿¡¼­ ºñ¼ö¼úÀû Áö¹æ °¨¼Ò ½Ã¼úÀÇ ºñÀ²

ºñ¼ö¼úÀû ¼ö¼ú ÃÑ 5,285¸¸ 2,741.1°Ç

ºñ¼ö¼úÀû Áö¹æ°¨¼Ò¹ý 21¸¸ 7,277°Ç

Ãâó ±¹Á¦¹Ì¿ë¿Ü°úÇÐȸ(ISAPS) º¸°í¼­, 2021

±¹Á¦¹Ì¿ë¼ºÇü¿Ü°úÇÐȸ(ISAPS)ÀÇ º¸°í¼­¿¡ µû¸£¸é, ¹Ì±¹ÀÇ ºñ¼ö¼úÀû Áö¹æ °¨¼Ò ¹æ¹ýÀº 2021³â¿¡ ½ÃÇàµÈ Àüü ºñ¼ö¼úÀû ¼ö¼úÀÇ 29.1%¸¦ Â÷ÁöÇÕ´Ï´Ù. ¹Ì±¹ÀÇ ¸ðµç ºñ¼ö¼úÀû Áö¹æ °¨¼Ò ¹æ¹ý Áß 'Äð½ºÄÃÇÁÆÃ'ÀÌ °¡Àå ¸¹ÀÌ Ã¤Åõǰí ÀÖ½À´Ï´Ù.

Ç¥: ¹Ì±¹ °¢ ÁÖº° Äð½ºÄÃÇÁÆÃ ½Ã¼úÀÇ Æò±Õ ºñ¿ë(´ë·«ÀûÀÎ ºñ¿ë)

¹Ì±¹ °¢ ÁÖº° Æò±Õ ºñ¿ë(´ë·«ÀûÀÎ ºñ¿ë)

´º¿å(´º¿åÁÖ) 2,000-4,000 ´Þ·¯

½ÃÄ«°í(Àϸ®³ëÀÌÁÖ) 2,000-4,000 USD

¸¶Àֹ̾Ì(Ç÷θ®´ÙÁÖ) 1,000-4,000 ´Þ·¯

¿À½ºÆ¾(ÅØ»ç½ºÁÖ) 1,000-4,000´Þ·¯

·Î½º¾ØÁ©·¹½º(͏®Æ÷´Ï¾ÆÁÖ) 1,500-4,000 ´Þ·¯

ÂüÁ¶ Ãâó: AEDIT, LLC., 2022³â 2¿ù À¥»çÀÌÆ® Åë°èÀÚ·á

µû¶ó¼­ ¹Ì±¹ ½Ã¹ÎµéÀÇ Áö¹æ °¨¼Ò¸¦ À§ÇÑ 'Äð½ºÄÃÇÁÆÃ' ½Ã¼úÀÇ ³ôÀº äÅ÷üÀº ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Áß¿äÇÑ ¿äÀÎÀÔ´Ï´Ù.

»ê¾÷ ¹ßÀü°ú ¹Ì·¡ ±âȸ:

ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³Çϰí ÀÖ´Â ÁÖ¿ä ±â¾÷µéÀÇ ´Ù¾çÇÑ Àü·«Àû °³Ã´Àº ´ÙÀ½°ú °°½À´Ï´Ù.

2023³â 3¿ù, CUTERA, INC.ÀÇ 'Æ®·ç¹Ùµð(TruBody)' ºê·£µå´Â 15ºÐ Ä¡·á ¿É¼ÇÀ¸·Î Áö¹æ °¨¼Ò¿Í ±ÙÀ° °­È­¸¦ À§ÇÑ ¸ÂÃãÇü, Æí¸®ÇÏ°í ¿Ïº®ÇÑ Á¢±ÙÀ» À§ÇÑ ÀÓ»óÀûÀ¸·Î ÀÔÁõµÈ ±â¼úÀÌÀÚ ¼ö»ó °æ·Â¿¡ ºû³ª´Â Á¦Ç°ÀÔ´Ï´Ù. ±ÙÀ° °­È­¸¦ À§ÇÑ Áö¹æ °¨¼Ò¸¦ ¸ñÇ¥·Î ÇÏ´Â Æ®·ç¹Ùµð ºê·£µå´Â ½Ã¼úÀÚ¿Í È¯ÀÚ°¡ ÃÖÀûÀÇ °á°ú¸¦ ¾òÀ» ¼ö ÀÖµµ·Ï ½Å¼ÓÇϰí È¿°úÀûÀÎ º¹ÇÕÀû Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.

ºñħ½ÀÀû Áö¹æ°¨¼Ò ½ÃÀå µ¿Çâ

ºñħ½ÀÀû Áö¹æ °¨¼Ò¸¦ À§ÇÑ ·Îº¿ °øÇÐ

Dominion Aesthetic Technologies, Inc.ÀÇ EONÀº ÇÁ·Î±×·¡¹Ö °¡´ÉÇÑ ´Ù°üÀý ·Îº¿ ÆÈÀ» žÀçÇÏ°í ¼¾¼­¸¦ ÅëÇØ ½Åü °íÀ¯ÀÇ ÁöÇüÁö¹°À» ¸ÅÇÎÇÏ¿© 100% °³ÀÎ ¸ÂÃãÇü Ä¡·á¹ýÀ» Á¦½ÃÇÏ´Â µî ±â¼úÀûÀ¸·Î Áøº¸µÈ ºñħ½ÀÀû Áö¹æ °¨¼Ò Á¦Ç°À» Ãâ½ÃÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ¼¾¼­·Î ½Åü °íÀ¯ÀÇ ÅäÆ÷±×·¡ÇǸ¦ ¸ÅÇÎÇÏ¿© 100% °³ÀÎÈ­µÈ Ä¡·á¹ýÀ» ¼³¸íÇÕ´Ï´Ù. ¶ÇÇÑ, ÇÁ·Î±×·¡¹Ö °¡´ÉÇÑ ´Ù°üÀý ·Îº¿ ÆÈÀº ´Ù¸¥ Áö¹æ À±°û ±â°èº¸´Ù ½Åü¸¦ ´õ Àß ÀÌÇØÇϰí Àüü Ä¡·á ºÎÀ§¸¦ ¸ÅÇÎÇÒ ¼ö ÀÖ¾î ºÒ±ÔÄ¢ÇÑ °á°úÀÇ °¡´É¼ºÀ» ÁÙÀÌ°í Æí¾ÈÇÔ ¼öÁØÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. FDA ½ÂÀÎÀ» ¹ÞÀº Á¦Ç°ÀÔ´Ï´Ù. ·¹ÀÌÀú Ä¡·á´Â ¿øÄ¡ ¾Ê´Â Áö¹æ¼¼Æ÷¸¦ ´ë»óÀ¸·Î ÇÏ´Â ¹Ý¸é, EONÀº ½ÅüÀÇ ´Ù¸¥ ºÎÀ§¿¡ ÇØ¸¦ ³¢Ä¡Áö ¾Ê°í º¹ºÎ Áö¹æ¸¸À» ´ë»óÀ¸·Î ÇÏ¿© È¿°úÀûÀÎ °á°ú¸¦ ¸¸µé¾î ³À´Ï´Ù. ¿¹¸¦ µé¾î, ¾ÆÆ÷Åä½Ã½º ½Ã¼úÀÇ °æ¿ì, EONÀº ·Îº¿ ÆÈÀ» ÅëÇØ ÀϰüµÇ°í °­·ÂÇÑ ·¹ÀÌÀú ¿¡³ÊÁö¸¦ Á¶»çÇÏ¿© ÇÇÇÏ Áö¹æ¼¼Æ÷¸¦ ¿µ±¸ÀûÀ¸·Î Á¦°ÅÇϸç, Á¦Æ® ÀÓÇÉÁö¸ÕÆ®´Â Æí¾ÈÇÏ°í ¾ÈÀüÇÑ È¯ÀÚ °æÇèÀ» º¸ÀåÇÕ´Ï´Ù. EONÀÇ Ä¡·á ½Ã°£Àº ¾à 20ºÐÀ̸ç, Àüü Ä¡·á´Â 60ºÐ À̳»¿¡ ¿Ï·áµÇ¸ç, ´Ù¿îŸÀÓÀÌ ÇÊ¿äÇÏÁö ¾Ê½À´Ï´Ù. ÀÌ Ä¡·á ½Ã°£Àº ½ÃÁß¿¡ ³ª¿ÍÀÖ´Â ´Ù¸¥ Áö¹æ °¨¼Ò Ä¡·á±â¿Í ºñ±³ÇÒ ¶§ ÇöÀúÇÏ°Ô Âª½À´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ Ã·´Ü ·Îº¿ µµÀÔ ±â¼úÀº Àå±âÀûÀ¸·Î È¿°úÀûÀÎ Áö¹æ °¨¼Ò °á°ú¿Í ȯÀÚÀÇ ¾ÈÀü¼ºÀ» º¸ÀåÇÕ´Ï´Ù. µû¶ó¼­ ºñħ½ÀÀû Áö¹æ °¨¼Ò ¹æ¹ýÀ» ¼öÇàÇϱâ À§ÇØ ·Îº¿À» »ç¿ëÇÏ´Â °ÍÀº ÇâÈÄ ¸î ³â µ¿¾È ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °¡´É¼ºÀÌ ³ôÀº »õ·Î¿î Æ®·»µå·Î ÀÛ¿ëÇÒ °ÍÀÔ´Ï´Ù.

°æÀï »óȲ ¹× ÁÖ¿ä ±â¾÷:

Cynosure LLC, Alma Lasers Ltd, Cutera Inc, Fotona, Sciton, Inc, Lynton Lasers Ltd, Solta Medical, Lumenis, Venus Concept Inc, Candela Corporation, ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀå º¸°í¼­¿¡ ÇÁ·ÎÆÄÀϸµ µÈ Àú¸íÇÑ ±â¾÷ Áß ÇϳªÀÔ´Ï´Ù. ÀÌµé ±â¾÷Àº ½Å±â¼ú °³¹ß, ±âÁ¸ Á¦Ç° ¾÷±×·¹À̵å, ¼¼°è ¼ÒºñÀÚ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇÑ Áö¸®Àû ÀÔÁö È®´ë¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀå »óȲ

Á¦5Àå ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀå - ÁÖ¿ä ½ÃÀå ¿ªÇÐ

Á¦6Àå ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀå : ¼¼°è ½ÃÀå ºÐ¼®

Á¦7Àå ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀå ºÐ¼® - ±â¼úº°

Á¦8Àå ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀå ºÐ¼® - ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ºñħ½ÀÀû Áö¹æ °¨¼Ò ½ÃÀå - Áö¿ªº° ºÐ¼®

Á¦10Àå ¾÷°è »óȲ

Á¦11Àå ±â¾÷ °³¿ä

Á¦12Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The noninvasive fat reduction market size is projected to grow from US$ 1.8 billion in 2023 to US$ 6.1 billion by 2031; the market is estimated to record a CAGR of 16.5% during 2023-2031. The rising demand for nonsurgical fat reduction procedures propels the noninvasive fat reduction market growth. However, complications associated with noninvasive fat reduction procedures impede the market growth.

Report Segmentation and Scope:

The noninvasive fat reduction market analysis has been carried out by considering the following segments: technology and end user.

Growth Drivers:

Rising Demand for Nonsurgical Fat Reduction Procedures

Nonsurgical fat reduction involves the removal of fat cells from target areas by inducing apoptosis, which can result in the reduction of subcutaneous fat pockets (fat deposited beneath the skin and above the muscle). Nonsurgical fat reduction procedures implement advanced techniques such as cryolipolysis, injection lipolysis, radiofrequency lipolysis, and laser lipolysis.

Fig: Number of Nonsurgical Fat Reduction Procedures--Global and Country-Wise Data

Nonsurgical Fat Reduction (2021)

CountryNo. of Procedures% Change 2020 vs 2021 (Global)

Global730,980+ 30.40%

US217,277

Mexico27,895

Germany11,455

Italy9,816

Spain7,056

Japan122,696

India9,600

Brazil33,720

Argentina55,360

Source: International Society of Aesthetic Plastic Surgery Report

Fig: Number of Nonsurgical Fat Reduction Procedures Performed in 2021 by Age Group

Age GroupNo. of Procedures

18 Years or Younger 24,488

19-34 Years 284,790

35-50 Years 323,166

51-64 Years 87,937

65 Years and Older 10,599

Source: International Society of Aesthetic Plastic Surgery Report

Fig: Nonsurgical Fat Reduction Procedures Performed in2021 by Gender

FemaleMale

605,669 125,311

Source: International Society of Aesthetic Plastic Surgery Report

By technology, the noninvasive fat reduction market is segmented into cryolipolysis, laser lipolysis, ultrasound, and others. The cryolipolysis segment held the largest noninvasive fat reduction market share in 2023 and is anticipated to register the highest CAGR of 17.8% during 2023-2031. Cryolipolysis, commonly known as "CoolSculpting," is a procedure implemented to break down fat cells by exposing the targeted area to cold temperatures. It is one of the most safe and effective cosmetic procedures performed worldwide for localized fat reduction. The American Society of Plastic Surgeons 2024 report revealed that 450,000 cryolipolysis procedures were performed globally.

Regional Analysis:

The scope of the noninvasive fat reduction market report entails North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America held the largest noninvasive fat reduction market share. The US is the largest contributor to the market in North America. Rising consciousness among Americans to improve physical appearance and overall wellness has been observed. Americans adopt body contouring procedures post-bariatric surgeries to sculpt their body in order to improve their overall physique. According to the American Society of Plastic Surgeons 2024 report, approx. 70% of Americans are transitioning toward nonsurgical fat reduction procedures to quickly tackle obesity.

Table: Number of Nonsurgical Fat Reduction Procedures and Nonsurgical Procedures Performed in US

ParametersEstimates% of Nonsurgical Fat Reduction Procedures From Total Nonsurgical Procedures

Total Nonsurgical Procedures528,52741.1%

Nonsurgical Fat Reduction217,277

Source: International Society of Aesthetic Plastic Surgery (ISAPS) report, 2021

The International Society of Aesthetic Plastic Surgery (ISAPS) report further reveals that nonsurgical fat reduction procedures in the US accounted for 29.1% of the total nonsurgical procedures performed in 2021. Among all the nonsurgical fat reduction procedures in the US, "CoolSculpting" is highly adopted.

Table: Average CoolSculpting Procedure Cost in US States (Approx.)

StateAverage Cost US$ (Approx.)

New York (New York)2,000-4,000

Chicago (Illinois)2,000-4,000

Miami (Florida)1,000-4,000

Austin (Texas)1,000-4,000

Los Angeles (California)1,500-4,000

Source: AEDIT, LLC., FEBRUARY 2022 STATS FROM THE WEBSITE

Therefore, the high adoption of "CoolSculpting" procedures for fat reduction among US citizens is the key factor influencing the noninvasive fat reduction market.

Industry Developments and Future Opportunities:

Various strategic developments by leading players operating in the noninvasive fat reduction market are listed below:

In March 2023, CUTERA, INC.'s "truBody" brand is an award-winning product that is clinically proven technologies for a customized, convenient, and complete approach to fat reduction and muscle toning with 15-minute treatment options. The truBody brand's "truSculpt" is intended for fat reduction for muscle toning and is a fast and effective combination approach, allowing practitioners and patients to achieve optimal results.

Noninvasive Fat Reduction Market Trends

Robotics to Perform Noninvasive Fat Reduction Procedures

Companies are trying to launch technologically advanced, noninvasive, fat-reducing products. Dominion Aesthetic Technologies, Inc.'s EON is one such example. EON includes a programmable articulated robotic arm that uses sensors to map the body's unique topography, providing 100% personalized treatment. Also, the programmable articulated robotic arm understands the body better than other fat contouring machines; it is capable of mapping the entire treatment area, reducing the chances of irregular results and increasing comfort levels. EON is an FDA-cleared product that has been proven safe, effective, and better than laser treatment. Laser treatment targets unwanted fat cells, while EON targets only abdominal fat without causing any harm to the rest of the body, producing effective results. For example, during the apoptosis procedure, EON permanently removes subcutaneous fat cells by delivering consistent and powerful laser energy through the robotic arm, whereas jet impingement ensures a comfortable and safe patient experience. Treatment by EON takes about 20 minutes, with the whole treatment being completed within 60 minutes, requiring no downtime. This treatment time is remarkably short compared to other fat-reduction treatment machines that exist in the market. Therefore, such advanced robotic delivery technologies provide effective fat reduction results and patient safety in the long run. Thus, the use of robotics to perform noninvasive fat reduction procedures acts as a new trend that is likely to boost the noninvasive fat reduction market growth in the coming years.

Competitive Landscape and Key Companies:

Cynosure LLC, Alma Lasers Ltd, Cutera Inc, Fotona, Sciton, Inc., Lynton Lasers Ltd, Solta Medical, Lumenis, Venus Concept Inc, and Candela Corporation are among the prominent companies profiled in the noninvasive fat reduction market report. These companies focus on developing new technologies, upgrading existing products, and expanding their geographic presence to meet the growing consumer demand worldwide.

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Noninvasive Fat Reduction Market Landscape

5. Noninvasive Fat Reduction Market - Key Market Dynamics

6. Noninvasive Fat Reduction Market - Global Market Analysis

7. Noninvasive Fat Reduction Market Analysis - by Technology

8. Noninvasive Fat Reduction Market Analysis - by End Users

9. Noninvasive Fat Reduction Market - Geographical Analysis

10. Industry Landscape

11. Company Profiles

12. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â